Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1995
04/19/1995EP0648217A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage
04/19/1995EP0648214A1 Fungicidally active compounds
04/19/1995EP0648213A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists
04/19/1995EP0648212A1 Heterocyclic compounds as pharmaceutical
04/19/1995EP0648209A1 Contrast agents for mr diagnosis
04/19/1995EP0648208A1 Indole derivatives as testosterone 5 alpha-reductase inhibitors
04/19/1995EP0648206A1 Peptidyl derivatives and their use as metalloproteinase inhibitors
04/19/1995EP0648205A1 Peptidyl derivatives as metalloproteinase inhibitors
04/19/1995EP0648126A1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer
04/19/1995EP0648122A1 PREVENTING TISSUE ADHESION USING -i(IN SITU) MODIFICATION OF ALGINATE.
04/19/1995EP0648120A1 Use of phosphonates for the treatment of osteoporosis
04/19/1995EP0648119A1 5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST $i(MYCOBACTERIUM TUBERCULOSIS)
04/19/1995EP0648118A1 Methods and products for treating presbyopia
04/19/1995EP0648117A1 Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
04/19/1995EP0648112A1 Precipitation of one or more active compounds in situ
04/19/1995EP0648108A1 Prophylactic and therapeutical preparation against caries.
04/19/1995EP0624096A4 Taxol as a radiation sensitizer.
04/19/1995EP0609460A4 Pharmaceutical agent with antitumoral activity.
04/19/1995EP0560868B1 Indan derivatives
04/19/1995EP0550635B1 Fused ring analogs of nitrogen containing nonaromatic heterocycles
04/19/1995EP0536182B1 Method of treating alopecia
04/19/1995EP0517796B1 Oligonucleotide analogs
04/19/1995EP0510036B1 2-substituted 4,5-diphenyl-imidazoles
04/19/1995EP0509009B1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
04/19/1995EP0468042B1 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1alpha-HYDROXYLATED DERIVATIVES
04/19/1995EP0451299B1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
04/19/1995EP0427783B1 Silicon containing reaction product
04/19/1995EP0243446B1 Alpha tocopherol-based vesicles
04/19/1995CN1101781A Pharmaceutical composition for treating cerebral thrombosis
04/19/1995CN1101780A Method and means for preventing secondary cataract
04/19/1995CN1101722A Ophthalmic lens with anti-toxin agent
04/19/1995CN1101649A Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical
04/19/1995CN1101648A Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical
04/19/1995CN1101644A Thiadiazinones
04/19/1995CN1101572A Tumor metastasis-suppressing agent and veterinary tumor metastasis-suppressing agent
04/19/1995CN1101554A Brain health nutriment and its producing method
04/19/1995CN1101551A Tablet for recovery of eye
04/19/1995CN1028236C Process for preparing acyl derivatives
04/19/1995CN1028235C Pyranobenzoxadiazole derivatives
04/19/1995CN1028233C Compound with gastric acid inhibitory effect and process for preparation
04/19/1995CN1028232C Therapeutically active substituted benzimidazole and process for its preparation
04/19/1995CN1028231C Therapeutically active compound and process for preparation
04/19/1995CN1028230C Process for preparing benzoheterocyclic compounds
04/19/1995CN1028229C Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical composition containing same and process for preparing them
04/19/1995CN1028227C Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same
04/19/1995CN1028225C New process for extracting levodopa by use of water percolation-ion exchange method
04/19/1995CN1028205C Use of dihydropyridine-3,5-dihydroxy acid easter derivatives
04/19/1995CA2117852A1 Bicyclic compounds as excitatory amino acid receptor antagonists
04/18/1995US5407962 Emulsions of highly fluorinated organic compounds for chemotherapy
04/18/1995US5407961 α-substituted benzenemethanamine derivatives and pharmaceutical use
04/18/1995US5407960 For cardiovascualr disorders, pain
04/18/1995US5407958 Therapeutic skin composition
04/18/1995US5407957 Production of docosahexaenoic acid by dinoflagellates
04/18/1995US5407956 Hypotensive agents, kidney disorders
04/18/1995US5407955 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
04/18/1995US5407954 Arylalkoxyphenoxy-imidazoline compounds
04/18/1995US5407953 Treating apnea/hypopnea/snoring in humans
04/18/1995US5407952 Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases
04/18/1995US5407951 Sulphonamidocycloalkane compounds, pharmaceutical compositions containing them, and methods of use thereof
04/18/1995US5407948 Substituted mono- and bipyridylmethylpyridones
04/18/1995US5407947 Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
04/18/1995US5407946 Pyrrolidine compounds which are useful as thromboxane AZ-inhibitors
04/18/1995US5407944 Compositions and methods for promoting hair growth
04/18/1995US5407943 Azaspiro quinolone antibacterial agents
04/18/1995US5407942 Biphenylmethyl-substituted pyridones
04/18/1995US5407941 Platelet activating factor antagonist and antihistamine; useful for treating asthma and allergic disorders
04/18/1995US5407940 New ellipticine compounds
04/18/1995US5407939 Fluorinated 17 β-substituted 4-aza-5 α-androstan-3-one derivatives
04/18/1995US5407935 Pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist
04/18/1995US5407933 Nitrogen-containing tetracyclic compounds having anti-allergic and anti-asthmatic activities and their use
04/18/1995US5407931 Bactericides
04/18/1995US5407929 Triazolylthiomethylthio cephalosporin hydrochhloride, its crystalline hydrate and the production of the same
04/18/1995US5407927 Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
04/18/1995US5407926 Ophthalmic composition
04/18/1995US5407925 Administering a cytolytic, pre-activated, bifunctional alkylating agent; antitumor agents
04/18/1995US5407924 Method of treating pain using inositol triphosphate
04/18/1995US5407923 Antiinflammatory agents
04/18/1995US5407922 Certain N-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties
04/18/1995US5407821 Genetic diagnosis of torsion dystonia
04/18/1995US5407815 R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation and pharmaceuticals containing this compound
04/18/1995US5407812 Crystalline 2-O-α-D-glucopyranosyl-L-ascorbic acid, and its preparation and uses
04/18/1995US5407808 Treating tumor with inhibitor of protoporphyrinogen conversion to heme
04/18/1995US5407688 Compositions and methods for treating gastrointestinal disorders
04/18/1995US5407687 Multilayer tablet for immediate and sustained release in treatment of esophagitis
04/18/1995US5407684 Use of DHEA as a medicinal
04/18/1995US5407683 Pharmaceutical solutions and emulsions containing taxol
04/18/1995US5407681 Increased feed efficiency
04/18/1995US5407676 Hydrophilic form of perfluoro compounds and a method of manufacture
04/18/1995US5407674 Plant extracts
04/18/1995US5407669 Inproved corneal preservation on storage
04/18/1995US5407663 Swishing solution in mouth, expectorating
04/18/1995CA2037487C Nitroglycerin pump spray
04/18/1995CA2022917C Synergistic skin depigmentation composition
04/18/1995CA2015475C Treating agent for osteoarthritis
04/18/1995CA1335286C Labile ketone derivatives of 3-substituted-1-alkylamino 2-propanols and their use as .beta.-adrenergic blockers
04/18/1995CA1335261C Fine-milled colestipol hydrochloride
04/18/1995CA1335259C Composition of spent liquor from pulping process for antiviral medicine
04/18/1995CA1335257C Solid pharmaceutical dosage in tablet triturate form and method of producing same
04/16/1995CA2118200A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same
04/16/1995CA2118195A1 Pharmaceutical composition